- Home
- NINE vs CNTB Comparison
NINE vs CNTB Comparison
Compare NINE & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- CNTB
- Stock Information
- Founded
- NINE 2011
- CNTB 2012
- Country
- NINE United States
- CNTB United States
- Employees
- NINE N/A
- CNTB N/A
- Industry
- NINE Oilfield Services/Equipment
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- NINE Energy
- CNTB Health Care
- Exchange
- NINE Nasdaq
- CNTB Nasdaq
- Market Cap
- NINE 49.6M
- CNTB 55.2M
- IPO Year
- NINE 2018
- CNTB 2021
- Fundamental
- Price
- NINE $1.20
- CNTB $0.87
- Analyst Decision
- NINE
- CNTB Strong Buy
- Analyst Count
- NINE 0
- CNTB 1
- Target Price
- NINE N/A
- CNTB $8.00
- AVG Volume (30 Days)
- NINE 1.1M
- CNTB 22.8K
- Earning Date
- NINE 03-05-2025
- CNTB 04-15-2025
- Dividend Yield
- NINE N/A
- CNTB N/A
- EPS Growth
- NINE N/A
- CNTB N/A
- EPS
- NINE N/A
- CNTB N/A
- Revenue
- NINE $556,751,000.00
- CNTB $24,116,000.00
- Revenue This Year
- NINE N/A
- CNTB N/A
- Revenue Next Year
- NINE $3.95
- CNTB $63.90
- P/E Ratio
- NINE N/A
- CNTB N/A
- Revenue Growth
- NINE N/A
- CNTB N/A
- 52 Week Low
- NINE $0.75
- CNTB $0.77
- 52 Week High
- NINE $3.26
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- NINE 48.24
- CNTB 37.85
- Support Level
- NINE $1.16
- CNTB $0.91
- Resistance Level
- NINE $1.24
- CNTB $0.95
- Average True Range (ATR)
- NINE 0.09
- CNTB 0.08
- MACD
- NINE -0.00
- CNTB -0.01
- Stochastic Oscillator
- NINE 58.58
- CNTB 27.95
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.